CREDIT SUISSE NEW ISSUE: 3 American Call Warrants on Novartis Donnerstag, 08. September 2022 - 12:04
Dear Investor
Please find hereafter the details for these new issues:
Ticker | Valor | ISIN | Underlying | Spot | Strike | Ratio | Maturity | Type | Issue price | Impl. Vola | PDF File |
NOVTCS | 12 141 4995 | CH 121 414 995 2 | Novartis AG | CHF 79.00 | CHF 84.00 | 15:1 | 15.09.2023 | Call | CHF 0.28 | 20.96% | |
NOVUCS | 12 141 4996 | CH 121 414 996 0 | Novartis AG | CHF 79.00 | CHF 92.00 | 15:1 | 15.09.2023 | Call | CHF 0.14 | 20.60% | |
NOVVCS | 12 141 4997 | CH 121 414 997 8 | Novartis AG | CHF 79.00 | CHF 100.00 | 15:1 | 15.09.2023 | Call | CHF 0.07 | 20.85% |
Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.
The warrants will be placed directly in the secondary market. Please call 044/335 76 00.
Kind regards
CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08
www.credit-suisse.com